Latest Period
Q4 2025
Security Snapshot
Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX) Institutional Ownership
CUSIP: 47010C888
13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025
Institutions Reporting
10
Shares (Excl. Options)
64,813
Price
$0.93
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- JAGX on Nasdaq
- Shares outstanding
- 6,991,905
- Price per share
- $0.56
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 64,813
- Total reported value
- $60,351
- % of total 13F portfolios
- 0%
- Share change
- -29,973
- Value change
- -$27,924
- Number of holders
- 10
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- JAGX - Jaguar Health, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 47010C888.
- 10 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 9 to 10 between Q3 2025 and Q4 2025.
- Reported value moved from $222,851 to $60,351.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 47010C888?
CUSIP 47010C888 identifies JAGX - Jaguar Health, Inc. - Common Stock, par value $0.0001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 47010C888:
Significant Owners of Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Mailman Joshua | 8.4% | $845,741 | 587,320 | Joshua Mailman | 17 Dec 2025 | |||
| Iliad Research & Trading, L.P. | 9.8% | $748,000 | 440,000 | Iliad Research & Trading, L.P. | 11 Dec 2025 | |||
| CVI Investments, Inc. | 4.6% | -53% | $346,470 | +$36,300 | 164,204 | +12% | CVI Investments, Inc. | 30 Sep 2025 |
| INTRACOASTAL CAPITAL, LLC | 5% | $779,374 | 65,002 | Mitchell P. Kopin | 20 May 2025 |
As of 31 Dec 2025, 10 institutional investors reported holding 64,813 shares of Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX). This represents 0.93% of the company’s total 6,991,905 outstanding shares.